Hydrochloric Acid → N-(1-(6-Chloro-2,3-dihydrobenzo[b][1,4]dioxin-8-yl)ethyl)-2-(methylsulfonyl)-5-(piperazin-1-yl)benzenamine hydrochloride
反応式
[Cl:1][C:2]1[CH:11]=[C:10]([CH:12]([NH:14][C:15]2[CH:20]=[C:19]([N:21]3[CH2:26][CH2:25][NH:24][CH2:23][CH2:22]3)[CH:18]=[CH:17][C:16]=2[S:27]([CH3:30])(=[O:29])=[O:28])[CH3:13])[C:5]2[O:6][CH2:7][CH2:8][O:9][C:4]=2[CH:3]=1.Cl>ClCCl.C(OCC)C>[ClH:1].[Cl:1][C:2]1[CH:11]=[C:10]([CH:12]([NH:14][C:15]2[CH:20]=[C:19]([N:21]3[CH2:22][CH2:23][NH:24][CH2:25][CH2:26]3)[CH:18]=[CH:17][C:16]=2[S:27]([CH3:30])(=[O:29])=[O:28])[CH3:13])[C:5]2[O:6][CH2:7][CH2:8][O:9][C:4]=2[CH:3]=1参加物
5
反応物 2
生成物 1
試薬・触媒・溶媒 2
実験手順
A solution of N-(1-(6-chloro-2,3-dihydrobenzo[b][1,4]dioxin-8-yl)ethyl)-2-(methylsulfonyl)-5-(piperazin-1-yl)benzenamine (50.0 mg, 0.11 mmol) in anhydrous dichloromethane (1 mL) was cooled to 0° C. and HCl (0.12 mL of a 1 M solution in diethyl ether, 0.12 mmol) was added. The mixture was allowed to stir for 30 min. The solvent was removed by rotary evaporation, more diethyl ether was added to precipitate the salt. After removal of solvent by rotary evaporation the desired product was collected (53 mg, 99%). 1H NMR (400 MHz, CD3OD): δ 7.55 (d, 1H), 6.87 (d, 1H), 6.76 (d, 1H), 6.40 (dd, 1H), 6.02 (d, 1H), 4.84 (m, 1H), 4.33 (m, 2H), 4.27 (m, 2H), 4.43 (m, 4H), 3.30 (m, 4H), 3.07 (s, 3H), 1.54 (d, 3H); MS (ESI) m/z: 452.3 (M++1).
後処理
- customThe solvent was removed by rotary evaporation, more diethyl ether
- additionwas added
- customto precipitate the salt
- customAfter removal of solvent
- customby rotary evaporation the desired product
- customwas collected (53 mg, 99%)
出典と根拠
- ORDレコード
- ord-3ddacbc5b35c4c938eb21c63726d912a
- 出典データセット
- uspto-grants-2013_12
- 特許番号
- US08604021B2
反応ノート
読み込み中…